Literature DB >> 7014445

Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.

Y Sanchez, I Ionescu-Matiu, G R Dreesman, W Kramp, H R Six, F B Hollinger, J L Melnick.   

Abstract

Complete Freud adjuvant, aluminum gel, and liposomes were compared for their ability to enhance the immunogenicity of an intact 22-nm HBsAg particle vaccine and an HBsAg-derived polypeptide vaccine in guinea pigs. Both humoral and cell-mediated immune responses were evaluated. The greatest immune response was obtained with complete Freund adjuvant, regardless of the antigen preparation. Aluminum gel appeared to be a better adjuvant for 22-nm HBsAg particles, but the liposomes rendered polypeptide preparations more immunogenic. The possibility that various proportions were entrapped in aqueous compartments instead of being inserted into the lipid bilayers of liposomes might account for this difference. The development of both humoral and cellular immunity was dependent upon the use of an adjuvant, because aqueous preparations had poor immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7014445      PMCID: PMC551376          DOI: 10.1128/iai.30.3.728-733.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

Authors:  G A Cabral; R Chairez; F Marciano-Cabral; M Suarez; G R Dreesman; J L Melnick; F B Hollinger
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  A simple device for making emulsified vaccines.

Authors:  B S BERLIN; R W McKINNEY
Journal:  J Lab Clin Med       Date:  1958-10

3.  Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen.

Authors:  E K Manesis; C H Cameron; G Gregoriadis
Journal:  FEBS Lett       Date:  1979-06-01       Impact factor: 4.124

4.  The carrier potential of liposomes in biology and medicine (first of two parts).

Authors:  G Gregoriadis
Journal:  N Engl J Med       Date:  1976-09-23       Impact factor: 91.245

5.  Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods.

Authors:  F B Hollinger; V Vorndam; G R Dreesman
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

6.  Summary of an international workshop on hepatitis B vaccines.

Authors:  R J Gerety; E Tabor; R H Purcell; F J Tyeryar
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

7.  Host components in hepatitis B antigen.

Authors:  C J Burrell
Journal:  J Gen Virol       Date:  1975-05       Impact factor: 3.891

8.  Incorporation of hepatitis-B surface antigen (HBsAg) into liposomes.

Authors:  E K Manesis; C H Cameron; G Gregoriadis
Journal:  Biochem Soc Trans       Date:  1978       Impact factor: 5.407

9.  Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBs Ag).

Authors:  G R Dreesman; F B Hollinger; J L Melnick
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

10.  Immunisation against hepatitis B in man.

Authors:  P Maupas; A Goudeau; P Coursaget; J Drucker; P Bagros
Journal:  Lancet       Date:  1976-06-26       Impact factor: 79.321

View more
  9 in total

1.  Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.

Authors:  D Davis; G Gregoriadis
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

2.  In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.

Authors:  P T Naylor; H S Larsen; L Huang; B T Rouse
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

3.  Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.

Authors:  R L Richards; M D Hayre; W T Hockmeyer; C R Alving
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

4.  Liposome potentiation of humoral immune response to lipopolysaccharide and O-polysaccharide antigens of Brucella abortus.

Authors:  J P Wong; J W Cherwonogrodzky; V L Di Ninno; L L Stadnyk; M H Knodel
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

5.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

Authors:  J H Eldridge; J K Staas; J A Meulbroek; T R Tice; R M Gilley
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

6.  Anti-idiotype immunization of cancer patients: modulation of the immune response.

Authors:  D Herlyn; M Wettendorff; E Schmoll; D Iliopoulos; I Schedel; U Dreikhausen; R Raab; A H Ross; H Jaksche; M Scriba
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice.

Authors:  T A Thomson; J Hilfenhaus; H Moser; P S Morahan
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis.

Authors:  S Nagafuchi; S Kashiwagi; S Hayashi; T Inoue; S Imayama; M Takeshita; M Kikuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

9.  Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype.

Authors:  R C Kennedy; G R Dreesman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.